- Results in 12 minutes
- Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in nasal swab specimens during the acute phase of infection.
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2.
- Rapid microfluidic immunofluorescence assay test method
- LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization only.
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests.
- Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
- LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument.
- 48 tests
- SKU:
- L016000109048--LI
Lombart Instruments L016000109048 - Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived
- Item Number:
- L016000109048
- Manufacturer:
- Lombart Instruments
Estimated Shipping 3-5 Business Days*Similar Poducts
Quidel 20374 - Respiratory Test Kit Sofia® SARS Antigen FIA 25 Tests CLIA Waived
SKU: 20374--QL
$607.50
